NCT06935058

Brief Summary

Kayaking requires high energy expenditure and optimal metabolic adaptation for performance and recovery. While research on other sports exists, the effects of chocolate milk on kayakers' recovery remain unexplored. Intensive kayaking induces physical stress, necessitating precise energy balance monitoring. This study evaluates metabolic and inflammatory markers, including glucose, glycogen, insulin, creatine kinase (CK), interleukin-6 (IL-6), ghrelin, leptin, peptide YY, peripheral blood morphology, and blood gas parameters to assess fatigue and recovery. Chocolate milk, with its ideal carbohydrate-to-protein ratio, supports glycogen replenishment, muscle repair, hydration, and oxidative stress reduction. Studies suggest it may outperform commercial sports drinks in endurance recovery by limiting muscle damage, inflammation, and improving acid-base balance. Findings will reveal whether chocolate milk enhances energy recovery, reduces muscle damage, and mitigates inflammation, contributing to endurance sports nutrition strategies

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 3, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 18, 2025

Completed
6 months until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2025

Completed
Last Updated

November 28, 2025

Status Verified

June 1, 2025

Enrollment Period

2 months

First QC Date

April 3, 2025

Last Update Submit

November 23, 2025

Conditions

Keywords

insulinkayakersgrelinglucoseglycogenregenerationfatigue

Outcome Measures

Primary Outcomes (26)

  • Changes from baseline in Glycogen level.

    Concentration of glycogen \[ng/mL\]. Immunoenzymatic assay method using a diagnostic ELISA Kit

    Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

  • Changes from baseline Insulin level.

    Concentration of insulin \[μIU/mL\]. Immunoenzymatic assay method using a diagnostic ELISA Kit

    Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption..

  • Changes from baseline Creatine kinase activity (CK) level.

    Concetration of CK \[ng/ml\]. Immunoenzymatic assay method using a diagnostic ELISA Kit

    Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

  • Changes from baseline interleukin-6 (Il-6) level.

    Concentration of Il-6 \[pg/mL\]. Immunoenzymatic assay method using a diagnostic ELISA Kit

    Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

  • Changes from baseline in lactic acid (LA) level.

    Concetration of LA \[mmol/l\]. Using a portable biochemical photometer Vario Photometer II (Diaglobal, Berlin, Germany) (capillary blood from the ear lobe).

    Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

  • Baseline Appetite Assessment of Athletes Before Exercise Test Using Visual Analogue Scale (VAS).

    The Visual Analogue Scale (VAS) measures subjective appetite sensations-linear scale from one to 10 where 10 is the strongest feeling.

    Day 1: At rest, after the exercise test.

  • Changes from baseline in leptin (LEP) level.

    Satiety regulation marker. Concentration of leptin \[pg/ml\].ELISA method by the test manufacturer's instructions.

    Day 1:At rest (before the test), directly after the test, and after a 1-hour post-consumption.

  • Changes from baseline in peptide YY (PYY) level.

    Satiety regulation marker. Concentration of leptin \[pg/ml\]. ELISA method by the test manufacturer's instructions.

    Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

  • Changes from baseline in ghrelin (GHRL) level.

    Hunger regulation marker. Concentration of GHRL \[pg/ml\].ELISA method by the test manufacturer's instructions.

    Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

  • Changes from baseline in acid-base balance - urea nitrogen (BUN) level.

    Concentration of BUN \[ml/dl\]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

    Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

  • Changes from baseline in acid-base balance - anion gap (AGAP) level.

    Concentration of AGAP \[mmol/l\]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

    Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

  • Changes from baseline in acid-base balance - excess base in extracellular fluid (BE ecf) level.

    Concentration of Be ecf \[mmol/l\]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

    Day1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

  • Changes from baseline in acid-base balance - sodium (Na) level.

    Concentration of Na \[mmol/l\]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

    Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

  • Changes from baseline in acid-base balance - calcium (Ca) level.

    Concentration of Ca \[mmol/l\]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

    Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

  • Changes from baseline in acid-base balance - potassium (K) level

    Concentration of K \[mmol/l\]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

    At rest (before the test), directly after the test, and after a 1-hour post-consumption.

  • Changes from baseline in acid-base balance - chlorine (Cl) level.

    Concentration of Cl \[mmol/l\]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

    Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

  • Changes from baseline in acid-base balance - bicarbonate level (cHCO3).

    Concentration of cHCO3 \[mmol/l\]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

    Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

  • Changes from baseline in acid-base balance - total plasma CO2 (tCO2) level.

    Concentration of tCO2 \[mmol/l\]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

    Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

  • Changes from baseline in acid-base balance - partial pressure of carbon dioxide (pCO2)

    Concentration of pCO2 \[mmol/l\]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

    Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

  • Changes from baseline in acid-base balance - partial pressure of oxygen (pO2)

    Concentration of pO2 \[mmol/l\]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

    Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

  • Changes from baseline in acid-base balance -total blood saturation (cSO2) level.

    Concentration of cSO2 \[mmol/l\]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

    Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

  • Changes from baseline in acid-base balance - urea level.

    Concentration of urea \[mmol/l\]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

    Day 1:At rest (before the test), directly after the test, and after a 1-hour post-consumption.

  • Changes from baseline in acid-base balance - crea level.

    Concentration of crea \[mg/dl\]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

    Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

  • Changes from baseline in acid-base balance - hematocrit [hct] level.

    Concentration of hct \[%\]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

    Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

  • Changes from baseline in acid-base balance - hemoglobin [chgb] level.

    Concentration of chgb \[mmol/l\]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

    Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

  • Changes from baseline in acid-base balance - glucose [glu] level.

    Concentration of glu \[mg/dl\]. Using the portable blood gas, electrolyte, and metabolite analyzer (epoc®) (capillary blood from the ear lobe).

    Day 1: At rest (before the test), directly after the test, and after a 1-hour post-consumption.

Secondary Outcomes (12)

  • Antropometric characteristic - height

    Day 1 after overall fast

  • Antropometric characteristic - weight

    Day 1 after overall fast

  • Antropometric characteristic - LBM

    Day 1 after overall fast

  • Antropometric characteristic - TBW

    Day 1 after overall fast

  • Antropometric characteristic - Water%

    Day 1 after overall fast

  • +7 more secondary outcomes

Study Arms (2)

Chocolade milk arm

EXPERIMENTAL

Participants will consume 400 ml of chocolate milk after exercise.

Other: Chocolade milk

Control arm

PLACEBO COMPARATOR

Participants will consume 400 ml of water after exercise.

Other: Water (Placebo)

Interventions

Participants will drink 400 ml of chocolate milk after exercise.

Chocolade milk arm

Participants will drink 400 ml of water after exercise.

Control arm

Eligibility Criteria

Age14 Years - 22 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Lack of consent for blood sampling,
  • injuries, health issues,
  • anti-inflammatory drugs,
  • performance-enhancing substances,
  • supplements within the last 3 months before the start of the study.

You may not qualify if:

  • consent to participate in the study,
  • regular training regimen,
  • current medical examinations,
  • no health contraindications.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Poznań University of Physical Education, Faculty of Physical Culture in Gorzów Wielkopolski

Gorzów Wielkopolski, Polska, 66-400, Poland

Location

MeSH Terms

Conditions

Insulin ResistanceFatigue

Interventions

Water

Condition Hierarchy (Ancestors)

HyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

HydroxidesAlkaliesInorganic ChemicalsAnionsIonsElectrolytesOxidesOxygen Compounds

Study Officials

  • Anna B Kasperska

    Poznan University of Physical Education

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Kayakers (both sexes), split into two groups: 1. experimental group (n=15, 400 ml of chocolate milk), 2. control group (n=15, 400 ml of water). Blood samples (capillary and venous) will be collected pre-exercise, post-exercise, and 1 hour post-consumption. All indicated parameters will be determined using the equipment of the biochemical laboratory of the University of Physical Education in Poznań, Branch in Gorzów Wielkopolski, and purchased commercial kits (immunoenzymatic ELISA tests). The analyses will be performed by the included project contractors.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

April 3, 2025

First Posted

April 18, 2025

Study Start

October 1, 2025

Primary Completion

November 15, 2025

Study Completion

November 15, 2025

Last Updated

November 28, 2025

Record last verified: 2025-06

Locations